Varex Imaging

VREX · NASDAQ

$18.40+$0.00 (+0.00%)TodayMarket closed · Oct 20, 7:30 PM ET

Prev close $18.40

VREX analyst rating

HoldConsensus of 4 analysts over the last 12 months. 25% rate it a buy.

Strong buy0
Buy1
Hold3
Underperform0
Sell0

12-month price target · 4 analysts

Average $19.84 (+7.8% upside)

Low: $19.09
Now: $18.40
High: $21.00

Upgrades and downgrades

The latest rating actions, newest first

VREX analyst upgrades, downgrades and rating actions
Firm	Date	Action	Rating	Price target	Hit rate
CJS Securities	Aug 17, 2026	Downgrade	Outperform → Market Perform	—	—
Oppenheimer	Aug 11, 2026	Downgrade	Outperform → Perform	—	44%
Sidoti & Co.	Aug 10, 2026	Downgrade	Buy → Neutral	$19.00	60%
B. Riley Securities	Nov 19, 2025	Maintains	Buy	$16.00	53%
Oppenheimer	Nov 19, 2025	Maintains	Outperform	$23.00 → $18.00	44%

The case for and against

Updated May 12, 2026

Bull case

Varex Imaging is on track for a strong recovery in both its Medical and Industrial segments, with sequential growth in both segments and record-setting performance in its Industrial segment in FY25. The company's strategic initiatives, including ramping production in India and developing new technologies such as photon counting CT detectors, position it for long-term growth and improved margins. With a strong cash position, end-customer stickiness, and attractive recurring revenue base, Varex is a deep-value name with a potential for positive surprises in the future.

Bear case

Varex Imaging is facing strong competition in the medical imaging market, with competitors such as GE Healthcare, Varian, Siemens, Philips, Elekta, Medtronic, Toshiba, and Canon. This competition, combined with the company's heavy reliance on the EMEA region for revenue, makes it vulnerable to economic fluctuations and geopolitical risks. Additionally, Varex Imaging's financial performance has been stagnant in recent years, with declining revenues and profitability, indicating potential underlying issues within the company's operations and strategy. Overall, these factors contribute to a negative outlook for Varex Imaging's stock.

Information on this page is provided for informational purposes only and is not a recommendation to buy, sell or hold any security. Investing involves risk, including possible loss of principal. Market data is delayed at least 15 minutes and is provided without warranty. Analyst ratings, price targets and company data come from third-party sources. Past performance does not guarantee future results.